Global Human Milk Oligosaccharides (HMO) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Human Milk Oligosaccharides (HMO) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at US$ 593 million in 2023 and is forecast to a readjusted size of USD 2644 million by 2030 with a CAGR of 24.0% during review period.

The core manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, DSM (Glycom) and Chr. Hansen (Jennewein). The top three companies hold about 83% of the market. North America is the world's largest Human Milk Oligosaccharides (HMO) market with a market share of about 54%, followed by Europe and Asia Pacific with a market share of 31% and 13%, respectively. In terms of product type, 2'-FL & 3-FL is the largest segments, accounting for approximately 96% of the market share. In terms of application, Infant Formula is the largest downstream sector, accounting for about 96% of the market share.

This report is a detailed and comprehensive analysis for global Human Milk Oligosaccharides (HMO) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Human Milk Oligosaccharides (HMO) market size and forecasts, in consumption value ($ Million), 2019-2030

Global Human Milk Oligosaccharides (HMO) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Human Milk Oligosaccharides (HMO) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Human Milk Oligosaccharides (HMO) market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Human Milk Oligosaccharides (HMO)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Human Milk Oligosaccharides (HMO) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Human Milk Oligosaccharides (HMO) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
2'-FL & 3-FL
LNT & LNnT, etc.

Market segment by Application
Infant Formula
Others

Market segment by players, this report covers
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
Elicityl SA
ZuChem

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Human Milk Oligosaccharides (HMO) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Human Milk Oligosaccharides (HMO), with revenue, gross margin, and global market share of Human Milk Oligosaccharides (HMO) from 2019 to 2024.

Chapter 3, the Human Milk Oligosaccharides (HMO) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Human Milk Oligosaccharides (HMO) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Human Milk Oligosaccharides (HMO).

Chapter 13, to describe Human Milk Oligosaccharides (HMO) research findings and conclusion.